NSEAnalysts/Institutional Investor Meet/Con. Call Updates5d ago · 14 Aug 2026, 06:55 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Natco Pharma Limited · NATCOPHARM

✦ AI SummaryResults

Natco Pharma Limited has informed the Exchange about the link of the recording of the earnings conference call held on August 14, 2026, for Q1 FY26-27.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Natco Pharma Limited has informed the Exchange about Link of Recording

Attachments (1)

📄

NATCOPHARM_14082026185528_Q1EarningscallAudioLink.pdf

pdf

Download →

View document text

14th August, 2026 Corporate Relationship Department Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd Mumbai 400 001 Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir Sub:- Audio weblink of earnings conference call held on August 14, 2026 Ref:- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 We are providing herewith the Audio weblink of the Company's earnings conference call for Q1 FY26-27 held on August 14, 2026. The same available on the website of the Company athttps://admin.natcopharma.co.in/wp-content/uploads/2026/08/Q1FY27.mp3 Thanking you Yours faithfully For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer